Risk Evaluation and Mitigation Strategy Programs to Promote Appropriate Medication Use and Knowledge: Patient Experiences with REMS Programs (CDER)

Data To Support Social and Behavioral Research as Used by the Food and Drug Administration

Recruitment Research Match - All Drugs - Patient Only

Risk Evaluation and Mitigation Strategy Programs to Promote Appropriate Medication Use and Knowledge: Patient Experiences with REMS Programs (CDER)

OMB: 0910-0847

Document [docx]
Download: docx | pdf

Risk Evaluation and Mitigation Strategy (REMS) Programs to Promote Appropriate Medication Use and Knowledge: Patient Experiences with REMS Programs

Recruitment Messages


Research Match-All Drugs Except Clozapine and Pegvaliase-pqpz (2000 Characters)


The purpose of this research study is to assess the impact of FDA risk evaluation and mitigation strategy (REMS) programs on health care delivery. One-hour interviews with patients enrolled in select REMS programs will be used to assess patient experiences. Participants who complete an interview will receive a $50 Amazon gift card as a token of appreciation.


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorMayookha Mitra-Majumdar
File Modified0000-00-00
File Created2022-05-23

© 2024 OMB.report | Privacy Policy